US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist

2.3100
-0.1000-4.15%

Trading Apr 19 14:00 ET

432.01MMarket Cap-2406P/E (TTM)

Taysha Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

517.55%15.45M

44.04%3.6M

4.75M

2.4M

4.71M

2.5M

Operating revenue

517.55%15.45M

44.04%3.6M

--4.75M

--2.4M

--4.71M

--2.5M

--0

Cost of revenue

Gross profit

Operating expense

-32.45%86.83M

-3.23%19.4M

-19.94%20.38M

-22.75%25.78M

-57.17%21.27M

-25.82%128.53M

-59.68%20.05M

-49.77%25.46M

-18.15%33.37M

54.72%49.65M

Selling and administrative expenses

-19.57%30.05M

-8.47%6.72M

-1.08%8.59M

-39.31%5.99M

-23.70%8.75M

-9.59%37.36M

-37.82%7.34M

-22.15%8.68M

-2.59%9.87M

39.25%11.47M

-General and administrative expense

-19.57%30.05M

-8.47%6.72M

-1.08%8.59M

-39.31%5.99M

-23.70%8.75M

-9.59%37.36M

-37.82%7.34M

-22.15%8.68M

-2.59%9.87M

39.25%11.47M

Research and development costs

-37.72%56.78M

-0.20%12.68M

-29.71%11.79M

-15.80%19.79M

-67.23%12.51M

-30.90%91.17M

-66.49%12.71M

-57.56%16.77M

-23.29%23.51M

60.07%38.18M

Operating profit

43.37%-71.37M

9.97%-15.8M

38.59%-15.63M

29.93%-23.38M

66.65%-16.56M

27.26%-126.03M

64.71%-17.55M

49.77%-25.46M

18.15%-33.37M

-54.72%-49.65M

Net non-operating interest income expense

59.82%-1.43M

209.22%1.21M

66.14%-362K

-69.97%-1.22M

-60.33%-1.06M

-182.56%-3.55M

-67.07%-1.11M

-111.26%-1.07M

-364.94%-716K

-1,096.97%-658K

Non-operating interest income

1,334.54%3.57M

865.33%1.92M

12,222.22%1.11M

725.93%223K

2,178.57%319K

44.77%249K

586.21%199K

-75.68%9K

-32.50%27K

-78.79%14K

Non-operating interest expense

31.60%5M

-45.36%713K

36.46%1.47M

93.81%1.44M

104.46%1.37M

165.97%3.8M

88.86%1.31M

98.53%1.08M

282.99%743K

--672K

Other net income (expense)

-6.39%-38.77M

271.11%62.33M

-10,109,000.00%-101.09M

200.00%3K

0.00%-8K

-36.44M

-36.43M

-1K

-3K

-8K

Gain on sale of security

---34.72M

--65.74M

---100.46M

----

Special income (charges)

93.24%-2.46M

94.93%-1.85M

---616K

----

---36.42M

--0

----

-Less:Impairment of capital assets

-97.08%1.07M

-98.77%449K

--616K

----

--36.42M

--0

----

-Less:Other special charges

--1.4M

----

Other non- operating income (expenses)

-8,705.56%-1.59M

-25,916.67%-1.56M

-1,800.00%-19K

200.00%3K

0.00%-8K

---18K

---6K

---1K

---3K

---8K

Income before tax

32.80%-111.57M

186.68%47.74M

-341.39%-117.09M

27.85%-24.6M

64.98%-17.62M

4.88%-166.01M

-9.31%-55.08M

48.18%-26.53M

16.70%-34.09M

-57.12%-50.32M

Income tax

Net income

32.80%-111.57M

186.68%47.74M

-341.39%-117.09M

27.85%-24.6M

64.98%-17.62M

4.88%-166.01M

-9.31%-55.08M

48.18%-26.53M

16.70%-34.09M

-57.12%-50.32M

Net income continuous Operations

32.80%-111.57M

186.68%47.74M

-341.39%-117.09M

27.85%-24.6M

64.98%-17.62M

4.88%-166.01M

-9.31%-55.08M

48.18%-26.53M

16.70%-34.09M

-57.12%-50.32M

Minority interest income

Net income attributable to the parent company

32.80%-111.57M

186.68%47.74M

-341.39%-117.09M

27.85%-24.6M

64.98%-17.62M

4.88%-166.01M

-9.31%-55.08M

48.18%-26.53M

16.70%-34.09M

-57.12%-50.32M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

32.80%-111.57M

186.68%47.74M

-341.39%-117.09M

27.85%-24.6M

64.98%-17.62M

4.88%-166.01M

-9.31%-55.08M

48.18%-26.53M

16.70%-34.09M

-57.12%-50.32M

Basic earnings per share

74.60%-0.96

125.79%0.2554

-43.08%-0.93

55.29%-0.38

78.79%-0.28

18.53%-3.78

25.00%-0.99

51.85%-0.65

22.02%-0.85

-51.72%-1.32

Diluted earnings per share

74.60%-0.96

125.79%0.2554

-43.08%-0.93

55.29%-0.38

78.79%-0.28

18.53%-3.78

25.00%-0.99

51.85%-0.65

22.02%-0.85

-51.72%-1.32

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	517.55%15.45M	44.04%3.6M	4.75M	2.4M	4.71M	2.5M	2.5M	0	0	0
Operating revenue	517.55%15.45M	44.04%3.6M	--4.75M	--2.4M	--4.71M	--2.5M	--2.5M	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-32.45%86.83M	-3.23%19.4M	-19.94%20.38M	-22.75%25.78M	-57.17%21.27M	-25.82%128.53M	-59.68%20.05M	-49.77%25.46M	-18.15%33.37M	54.72%49.65M
Selling and administrative expenses	-19.57%30.05M	-8.47%6.72M	-1.08%8.59M	-39.31%5.99M	-23.70%8.75M	-9.59%37.36M	-37.82%7.34M	-22.15%8.68M	-2.59%9.87M	39.25%11.47M
-General and administrative expense	-19.57%30.05M	-8.47%6.72M	-1.08%8.59M	-39.31%5.99M	-23.70%8.75M	-9.59%37.36M	-37.82%7.34M	-22.15%8.68M	-2.59%9.87M	39.25%11.47M
Research and development costs	-37.72%56.78M	-0.20%12.68M	-29.71%11.79M	-15.80%19.79M	-67.23%12.51M	-30.90%91.17M	-66.49%12.71M	-57.56%16.77M	-23.29%23.51M	60.07%38.18M
Operating profit	43.37%-71.37M	9.97%-15.8M	38.59%-15.63M	29.93%-23.38M	66.65%-16.56M	27.26%-126.03M	64.71%-17.55M	49.77%-25.46M	18.15%-33.37M	-54.72%-49.65M
Net non-operating interest income expense	59.82%-1.43M	209.22%1.21M	66.14%-362K	-69.97%-1.22M	-60.33%-1.06M	-182.56%-3.55M	-67.07%-1.11M	-111.26%-1.07M	-364.94%-716K	-1,096.97%-658K
Non-operating interest income	1,334.54%3.57M	865.33%1.92M	12,222.22%1.11M	725.93%223K	2,178.57%319K	44.77%249K	586.21%199K	-75.68%9K	-32.50%27K	-78.79%14K
Non-operating interest expense	31.60%5M	-45.36%713K	36.46%1.47M	93.81%1.44M	104.46%1.37M	165.97%3.8M	88.86%1.31M	98.53%1.08M	282.99%743K	--672K
Other net income (expense)	-6.39%-38.77M	271.11%62.33M	-10,109,000.00%-101.09M	200.00%3K	0.00%-8K	-36.44M	-36.43M	-1K	-3K	-8K
Gain on sale of security	---34.72M	--65.74M	---100.46M	----	----	----	----	----	----	----
Special income (charges)	93.24%-2.46M	94.93%-1.85M	---616K	----	----	---36.42M	---36.42M	--0	----	----
-Less:Impairment of capital assets	-97.08%1.07M	-98.77%449K	--616K	----	----	--36.42M	--36.42M	--0	----	----
-Less:Other special charges	--1.4M	----	----	----	----	----	----	----	----	----
Other non- operating income (expenses)	-8,705.56%-1.59M	-25,916.67%-1.56M	-1,800.00%-19K	200.00%3K	0.00%-8K	---18K	---6K	---1K	---3K	---8K
Income before tax	32.80%-111.57M	186.68%47.74M	-341.39%-117.09M	27.85%-24.6M	64.98%-17.62M	4.88%-166.01M	-9.31%-55.08M	48.18%-26.53M	16.70%-34.09M	-57.12%-50.32M
Income tax
Net income	32.80%-111.57M	186.68%47.74M	-341.39%-117.09M	27.85%-24.6M	64.98%-17.62M	4.88%-166.01M	-9.31%-55.08M	48.18%-26.53M	16.70%-34.09M	-57.12%-50.32M
Net income continuous Operations	32.80%-111.57M	186.68%47.74M	-341.39%-117.09M	27.85%-24.6M	64.98%-17.62M	4.88%-166.01M	-9.31%-55.08M	48.18%-26.53M	16.70%-34.09M	-57.12%-50.32M
Minority interest income
Net income attributable to the parent company	32.80%-111.57M	186.68%47.74M	-341.39%-117.09M	27.85%-24.6M	64.98%-17.62M	4.88%-166.01M	-9.31%-55.08M	48.18%-26.53M	16.70%-34.09M	-57.12%-50.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	32.80%-111.57M	186.68%47.74M	-341.39%-117.09M	27.85%-24.6M	64.98%-17.62M	4.88%-166.01M	-9.31%-55.08M	48.18%-26.53M	16.70%-34.09M	-57.12%-50.32M
Basic earnings per share	74.60%-0.96	125.79%0.2554	-43.08%-0.93	55.29%-0.38	78.79%-0.28	18.53%-3.78	25.00%-0.99	51.85%-0.65	22.02%-0.85	-51.72%-1.32
Diluted earnings per share	74.60%-0.96	125.79%0.2554	-43.08%-0.93	55.29%-0.38	78.79%-0.28	18.53%-3.78	25.00%-0.99	51.85%-0.65	22.02%-0.85	-51.72%-1.32
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall